JPWO2019208797A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019208797A5
JPWO2019208797A5 JP2020515615A JP2020515615A JPWO2019208797A5 JP WO2019208797 A5 JPWO2019208797 A5 JP WO2019208797A5 JP 2020515615 A JP2020515615 A JP 2020515615A JP 2020515615 A JP2020515615 A JP 2020515615A JP WO2019208797 A5 JPWO2019208797 A5 JP WO2019208797A5
Authority
JP
Japan
Prior art keywords
oxy
azetidin
carboxylic acid
hydroxy
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020515615A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019208797A1 (ja
JP7360132B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/018011 external-priority patent/WO2019208797A1/ja
Publication of JPWO2019208797A1 publication Critical patent/JPWO2019208797A1/ja
Publication of JPWO2019208797A5 publication Critical patent/JPWO2019208797A5/ja
Priority to JP2023156567A priority Critical patent/JP7598594B2/ja
Application granted granted Critical
Publication of JP7360132B2 publication Critical patent/JP7360132B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020515615A 2018-04-27 2019-04-26 オキソ置換化合物 Active JP7360132B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023156567A JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018087761 2018-04-27
JP2018087761 2018-04-27
PCT/JP2019/018011 WO2019208797A1 (ja) 2018-04-27 2019-04-26 オキソ置換化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023156567A Division JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Publications (3)

Publication Number Publication Date
JPWO2019208797A1 JPWO2019208797A1 (ja) 2021-05-27
JPWO2019208797A5 true JPWO2019208797A5 (https=) 2023-02-15
JP7360132B2 JP7360132B2 (ja) 2023-10-12

Family

ID=68295570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020515615A Active JP7360132B2 (ja) 2018-04-27 2019-04-26 オキソ置換化合物
JP2023156567A Active JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023156567A Active JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Country Status (15)

Country Link
US (3) US11702431B2 (https=)
EP (1) EP3786168A4 (https=)
JP (2) JP7360132B2 (https=)
KR (1) KR102679411B1 (https=)
CN (2) CN112135830B (https=)
AU (1) AU2019259818B2 (https=)
CA (1) CA3098433A1 (https=)
EA (1) EA202092579A1 (https=)
IL (1) IL278262B2 (https=)
MX (1) MX2020011367A (https=)
PH (1) PH12020551772A1 (https=)
SG (1) SG11202010661SA (https=)
TW (1) TWI829686B (https=)
UA (1) UA129150C2 (https=)
WO (1) WO2019208797A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020138499A1 (ja) * 2018-12-28 2021-11-04 大日本住友製薬株式会社 アルキル置換化合物
EP4049680A4 (en) * 2019-10-25 2024-01-10 Sumitomo Pharma Co., Ltd. NEW SUBSTITUTED CONDENSED RING CONNECTION
US11476003B2 (en) * 2020-12-15 2022-10-18 Biodesix, Inc. Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
WO2024128238A1 (ja) 2022-12-13 2024-06-20 住友ファーマ株式会社 細菌感染症の治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2705393A1 (en) 2007-11-13 2009-05-22 Protez Pharmaceuticals, Inc. Beta-lactamase inhibitors
AU2013355110B2 (en) 2012-12-07 2017-11-09 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
MX2015008627A (es) 2013-01-04 2015-09-23 Rempex Pharmaceuticals Inc Derivados de acido boronico y usos terapeuticos de los mismos.
KR20150103269A (ko) 2013-01-04 2015-09-09 렘펙스 파머수티클스 인코퍼레이티드 보론산 유도체 및 그의 치료적 용도
EP2943204B1 (en) 2013-01-10 2019-03-13 Venatorx Pharmaceuticals Inc Beta-lactamase inhibitors
EP2970340B1 (en) 2013-03-14 2020-02-12 Venatorx Pharmaceuticals, Inc. Beta-lactamase inhibitors
AU2015264418A1 (en) 2014-05-19 2016-11-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2015191907A1 (en) 2014-06-11 2015-12-17 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
WO2016003929A1 (en) 2014-07-01 2016-01-07 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US20180051041A1 (en) 2015-03-17 2018-02-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2017044828A1 (en) 2015-09-11 2017-03-16 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors

Similar Documents

Publication Publication Date Title
JPWO2019208797A5 (https=)
JP4302762B2 (ja) 複素環式芳香族キノリン化合物およびpde10阻害剤としてのその使用
US9403830B2 (en) Inhibitors of leukotriene production
US9278960B2 (en) Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
SA516371614B1 (ar) مركبات أزا حلقية ثنائية كمحفزات لمستقبل m1 و/أو مستقبل m4 مسكريني
RU2006127573A (ru) Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата
US20050009843A1 (en) Medicine for inhibiting drug elimination pump
USRE49700E1 (en) Substituted nitrogen containing compounds
US20090221574A1 (en) 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
US12590091B2 (en) 1H-pyrrolo[3,2-C]pyridine and 1H-pyrrolo[2,3-C]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
JP2018534328A5 (https=)
JP2007523182A5 (https=)
CA3042684A1 (en) Azole amides and amines as .alpha.v integrin inhibitors
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
HRP20211678T1 (hr) N-supstituirani derivati indola kao modulatori receptora pge2
AU2018230236B2 (en) Novel imidazo[4,5-c]quinoline derivatives as LRRK2 inhibitors
JP2021535134A5 (https=)
JP2023526841A (ja) ピペラジン環状尿素類
US10407422B2 (en) Triazolopyridine inhibitors of myeloperoxidase
US20230322770A1 (en) Substituted heteroaryl compounds useful as inhibitors of tlr9
US20230295145A1 (en) Pyrrolidine derivatives and methods of use
US20060106034A1 (en) Drug efflux pump inhibitor
US20200024272A1 (en) 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ror1 activity
ES2328225T3 (es) Derivados benzoheterociclicos inhibidores de la farnesil-transferasa.
JPS59196895A (ja) 6−(ヒドロキシアルキル)−2−(ヘテロアリ−ルアルキルチオ)ペネム類、それらの製造方法およびそれらを含む医薬組成物